ASML Holding N.V. (ASML) vs Merck & Co., Inc. (MRK)
See how ASML Holding N.V. and Merck & Co., Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$1,383.11
NasdaqGS
$143.37
NYSE
Merck & Co., Inc. develops pharmaceutical products across multiple therapeutic areas, including cardiometabolic disorders, oncology, and infectious diseases. In cancer treatment, its immuno-oncology portfolio, led by Keytruda, represents a significant driver of total revenue. The company also maintains a strong vaccines business focused on preventing pediatric illnesses, alongside Gardasil for human papillomavirus. In addition, Merck markets animal health products. Geographically, 47% of the company’s sales come from its U.S. human health segment, which includes pharmaceuticals and vaccines.
View Full PageKey Metrics Comparison
ASML Holding N.V.ASML
Market Cap$533.075B
Price$1,383.11
24h Change-1.68%
24h Volume$2.41M
Employees44,681
Shares OutstandingN/A
Merck & Co., Inc.MRK
Market Cap$353.442B
Price$143.37
24h Change-0.75%
24h Volume$7.26M
Employees73,000
Shares Outstanding2,469,879,206
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ASML
60.1%MRK
39.9%Volume Share
Share of combined 24h volume
ASML
24.9%MRK
75.1%24h Performance
Price change over last 24 hours
ASML
-1.68%MRK
-0.75%Price Comparison
ASML Holding N.V.
Merck & Co., Inc.